作者: J. B. Baker , D. Dutta , D. Watson , T. Maddala , S. Shak
DOI: 10.1200/JCO.2008.26.15_SUPPL.3512
关键词:
摘要: 3512 Background: The anti-EGFR monoclonal antibody cetuximab shows activity in a subset of patients with metastatic colorectal cancer (mCRC). This study was conducted to discover and validate marke...